subsequent challenge with virulent L. monocytogenes.
In farm animals, especially sheep, losses due to deaths from listeriosis can be considerable (21) . To protect against infection, killed and live attenuated strains have been used as vaccines in animals, but with little or no success (1, 3, 8, 13) . The failure of previous live attenuated strains as vaccines is probably due to the method of attenuation used (8, 13) .
An alternative to the procedures previously used for making attenuated strains is the generation of strains with a defined mechanism of attenuation. This approach is the basis of the suggestion that hemolysin-deficient strains of Listeria monocytogenes could be suitable as attenuated strains for vaccines (15) . However, use of these strains would exclude protection from the effects of hemolysin, an important virulence factor (18). Therefore, we decided to assess the potential of aromatic amino acid-dependent, hemolytic strains of L. monocytogenes (2) . Both strains were obtained from D. Portnoy, University of Pennsylvania, and maintained as described before (20 (5) .
In experiments to ascertain the numbers of bacteria in the livers and spleens, infected mice were killed by cervical dislocation at the desired times after infection. The spleens and livers were removed, weighed, and homogenized separately in 10 ml of sterile distilled water in a Stomacher-Lab blender (Seward Medical), and viable counts on tryptose agar were obtained (20) . Results were expressed as mean counts of viable listeriae per gram of tissue. To determine whether vaccination with Lm.918.6 conferred resistance to subsequent infection, mice were first vaccinated (intravenously) with 104 CFU of Lm.918.6 in water. The booster vaccination was an identical dose of Lm.918.6 given 14 days after the initial vaccination. At 28 days after the initial vaccination with Lm.918.6, the ED50 of Lm.1070138 for the mice was determined as described above. Data were analyzed by the Mann-Whitney U test (10) or the KolmogorovSmimov test (10) .
Lm.918.6 had been described previously as a Tn917 insertion mutant that required aromatic amino acids for growth (2) . To ensure that Lm.918.6 contained a single Tn917 insertion, a Southern blot was performed to EcoRIdigested chromosomal DNA with a radiolabelled Tn917-specific probe as described in reference 2. Uncut plasmid pTV32 was included as a positive control, as it carries a single copy of Tn917 (22) . The probe hybridized to a single EcoRI fragment (Fig. 1) Fig. 2A and B) Fig. 2A and B) . No significant difference (P > 0.05) in the = 0 clearance of the two strains between days 1 and 9 was noted, . ' 0.40 and by day 11, both strains had been cleared ( Fig. 2A and B (---). Each point represents the arithmetic mean for five mice. 2C ), but the duration was significantly reduced, with spleens returning to normal weight 11 days postinfection (Fig. 2C) . In contrast, with Lm.1070138, splenomegaly was maintained for at least 15 days postinfection (Fig. 2C) . (Table 2 ). In addition, a significant (P < 0.05) booster effect was seen when mice were given a second dose of Lm.918.6 14 days after the initial vaccination (Table 2) . Therefore, strain Lm.918.6 with a transposon insertion which affects pheA expression is attenuated in the mouse model for listeriosis. In the same system, it confers significant protection against infection by virulent L. monocytogenes, with a pronounced booster effect upon second vaccination. This is the first evidence that an auxotrophic mutant of L. monocytogenes can be attenuated in a manner similar to that described for aro mutants of S. typhimunium (17) . Why a marked reduction in pheA gene expression should result in attenuation is not yet clear. It has been hypothesized that in aroA mutants of S. typhimurium attenuation may be due to an inability to synthesize p-aminobenzoate and dihydroxybenzoate (7). Since Lm.918.6 should be capable of making both p-aminobenzoate and dihydroxybenzoate, attenuation in this case may reflect the poor availability of phenylalanine in mammalian cells. In addition, feedback inhibition of earlier aromatic pathway enzymes by the accumulation of prephenate, the substrate of prephenate dehydratase (9), may also be occurring. Reduced virulence ofpheA mutants of gram-negative or gram-positive bacteria has not, to our knowledge, been reported previously. Studies of aro mutants of Salmonella spp. (4, 11) suggest that a strain of L. monocytogenes with multiple lesions in the pathway of aromatic amino acid synthesis might prove to be more attenuated than Lm.918.6. Future studies will attempt to introduce such additional mutations into Lm.918.6. This should serve to increase the attenuation and also reduce the risk of possible reversions in vivo. It is entirely feasible that such strains could be useful as vaccines in farm animals.
In addition to their potential as vaccine strains, nonreverting aromatic amino acid-dependent mutants of L. monocytogenes may be exploited as carriers of cloned gram-positive virulence factors and protective antigens of other pathogens, as has been reported for similar strains of Salmonella (4, 14) .
